Close
Back to CTIC Stock Lookup

CTI BioPharma (CTIC) – Major News

May 10, 2023 04:10 AM CTI BioPharma (CTIC) Acquired by Sobi for $9.10/sh or $1.7B Cash
Aug 8, 2022 04:43 PM CTI BioPharma (CTIC) Misses Q2 EPS by 2c
May 12, 2022 04:29 PM CTI BioPharma (CTIC) Misses Q1 EPS by 4c
Jun 1, 2021 04:07 PM CTI BioPharma (CTIC) Misses Q1 EPS by 1c
Mar 17, 2021 04:21 PM CTI BioPharma (CTIC) Misses Q4 EPS by 4c
Nov 10, 2020 04:36 PM CTI BioPharma (CTIC) Reports In-Line Q3 EPS
Jul 9, 2018 07:02 AM CTI BioPharma (CTIC) Phase III Trial Evaluating PFS of PIXUVRI Combined with Rituximab in Patients with Aggressive B-cell NHL Did Not Meet Primary Endpoint
May 3, 2018 04:39 PM CTI BioPharma (CTIC) Tops Q1 EPS by 2c
Mar 7, 2018 04:04 PM CTI BioPharma (CTIC) Misses Q4 EPS by 4c
Nov 6, 2017 04:03 PM CTI BioPharma (CTIC) Reports Q3 Loss of $0.28
Aug 3, 2017 04:02 PM CTI BioPharma (CTIC) Reports Q2 EPS of $0.03
May 3, 2017 04:41 PM CTI BioPharma (CTIC) Misses Q1 EPS by 1c
Mar 2, 2017 04:02 PM CTI BioPharma (CTIC) Reports Q4 Loss of $0.23
Feb 27, 2017 06:18 AM CTI BioPharma (CTIC) Names Adam Craig as President and CEO
Oct 3, 2016 06:09 AM CTI BioPharma (CTIC) CEO Bianco to Retire
Feb 10, 2016 06:17 AM CTI BioPharma's (CTIC) Pacritinib Placed on Full Clinical Hold; NDA Withdrawn
Feb 8, 2016 06:00 AM FDA Places Partial Clinical Hold on CTI BioPharma's (CTIC) Pacritinib IND
Nov 5, 2015 04:14 PM CTI BioPharma (CTIC) Misses Q3 EPS by 7c
Sep 23, 2015 09:02 AM CTI BioPharma (CTIC) Completes pre-NDA Meeting on Pacritinib; Updates on PERSIST-1
Aug 6, 2015 04:55 PM CTI BioPharma (CTIC) Misses Q2 EPS by 9c
May 6, 2015 05:28 PM CTI BioPharma (CTIC) Misses Q1 EPS by 2c
Mar 12, 2015 04:25 PM CTI BioPharma (CTIC) Misses Q4 EPS by 9c, Offers Guidance
Mar 9, 2015 07:01 AM CTI BioPharma (CTIC), Baxter (BAX) Report PERSIST-1 Met Primary Enpoint
Jan 13, 2015 06:13 AM CTI BioPharma (CTIC) Sees Prelim. FY14 Revs at $60M; Guides FY15 Revenue Above Views
Aug 7, 2014 06:36 AM CTI BioPharma (CTIC) Pacritinib Granted FDA Fast Track Status
Apr 29, 2014 04:51 PM Cell Therapeutics Inc. (CTIC) Reports Q1 Loss of $0.20
Mar 4, 2014 04:02 PM Cell Therapeutics Inc. (CTIC) Posts Surprise Q4 Profit of 8c/Share
Nov 15, 2013 07:40 AM Baxter (BAX), Cell Therapeutics (CTIC) Enter Exclusive Pacritinib Pact
Feb 28, 2013 05:35 PM Cell Therapeutics Inc. (CTIC) Reports In-Line Q4 Loss of $0.20/Sh
Nov 1, 2012 06:13 AM Cell Therapeutics Inc. (CTIC) Narrows Q3 Loss to 38c/Share
Aug 1, 2012 07:44 AM Cell Therapeutics Inc. (CTIC) Widens Q2 Loss to 28c/Share
Apr 20, 2012 06:44 AM Cell Therapeutics (CTIC) Posts Narrower Q1 Loss of 9c/Share
Mar 7, 2012 06:55 AM Cell Therapeutics Inc. (CTIC) Posts Q4 Loss of 9c/Share
Oct 25, 2011 07:27 AM Cell Therapeutics (CTIC) Posts Q3 Loss of 16c/Share; Resubmits Pixantrone NDA to FDA
Jul 28, 2011 06:45 AM Cell Therapeutics, Inc. (CTIC) Narrows Q2 Loss
Apr 27, 2011 07:23 AM Cell Therapeutics, Inc. (CTIC) Misses Q4 EPS by 4c
Aug 5, 2010 08:16 AM Cell Therapeutics, Inc. (CTIC) Posts Mixed Q2 Earnings Results
Mar 22, 2010 01:21 PM Cell Therapeutics (CTIC) Provides Update on FDA Advisory Committee Meeting on Pixantrone
Sep 8, 2009 07:00 AM Cell Therapeutics (CTIC) Given April 23 PDUFA Date by FDA for Pixantron

Back to CTIC Stock Lookup